Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax - Wikidata - wikimedia - TriplyDB

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

http://www.wikidata.org/entity/Q24546050

about

Interaction of occupational and personal risk factors in workforce health and safety Interferon protects mice against inhalation anthrax Conference report on public health and clinical guidelines for anthrax Mechanistic modeling of emergency events: assessing the impact of hypothetical releases of anthrax An overview of anthrax infection including the recently identified form of disease in injection drug users Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits Modeling Tool for Decision Support during Early Days of an Anthrax Event Evaluation of early immune response-survival relationship in cynomolgus macaques after Anthrax Vaccine Adsorbed vaccination and Bacillus anthracis spore challenge.Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge Anthrax prevention and treatment: utility of therapy combining antibiotic plus vaccine.Bacillus anthracis spore entry into epithelial cells is an actin-dependent process requiring c-Src and PI3K.Levofloxacin cures experimental pneumonic plague in African green monkeys.New developments in vaccines, inhibitors of anthrax toxins, and antibiotic therapeutics for Bacillus anthracis.Combination therapy with antibiotics and anthrax immune globulin intravenous (AIGIV) is potentially more effective than antibiotics alone in rabbit model of inhalational anthrax.Recombinant protective antigen anthrax vaccine improves survival when administered as a postexposure prophylaxis countermeasure with antibiotic in the New Zealand white rabbit model of inhalation anthrax.Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis.Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.Cost-effectiveness comparison of response strategies to a large-scale anthrax attack on the chicago metropolitan area: impact of timing and surge capacity.Anthrax: an update.A mathematical simulation of the inflammatory response to anthrax infection.Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism.Pathology of inhalational anthrax animal models.Laboratory-acquired lethal infections by potential bioweapons pathogens including Ebola in 2014.Generation of a novel chimeric PALFn antigen of Bacillus anthracis and its immunological characterization in mouse model.Life sciences today and tomorrow: emerging biotechnologies.Licensure strategy for pre- and post-exposure prophylaxis of biothrax vaccine: the first vaccine licensed using the FDA animal rule.Risk-Based Decision Making for Reoccupation of Contaminated Areas Following a Wide-Area Anthrax Release.Antibiotics cure anthrax in animal models.Raxibacumab for inhalational anthrax: an effective specific therapeutic approach?

P2860

Q23919248-BDDBAFFF-1D11-4A52-9D0E-F62F158390EA Q28384715-3DA49D8F-FEF2-489E-A15A-0A6638B0775A Q28386084-3DC558B5-EAC9-4254-89DE-A3612305B9D9 Q28387276-D28BD6A6-C9A9-469C-8A7A-0A93A5F41EDA Q28392066-72C7FC55-1736-4387-946C-0B022B1CC9EE Q28394063-9C915364-1DC5-4064-A62A-E6DF198BA196 Q28396975-17EBF7F9-3B2B-409C-B526-2C591BE4A9DB Q30152051-3BFAC596-1D83-4A21-94B0-94BE668FACB5 Q33284583-F86E4B03-2A6B-4A3E-876E-4A4299C7188A Q33505445-8A037B3B-B6BC-484E-960E-DD2DDDBB32DD Q33638446-A02FDB2D-3C90-4702-B0D4-CF65F186AA01 Q33828874-4C8D3A4A-D0C2-46DB-887B-BA4648D38B6C Q34066161-B2246EF7-B92F-4A6B-81F0-202EA6187C2F Q34194627-88B39DA3-C8A6-4B83-AFDC-3A1C060A00A7 Q34303179-27B4C17E-6FA0-4218-B57C-A0786FF17B99 Q34368520-351DA95A-1931-4276-8EA5-5D6536702475 Q35129390-A1C77CDB-0B77-4A72-BA61-C420D5468DCF Q36229010-BBCA4960-0DCD-492F-B942-075CF678D816 Q36734177-31E878E6-D99A-4952-BEEE-133A6FBD7214 Q36846447-B0131DCD-08B2-4725-88BE-D6F4B12D31D4 Q36901955-FBD6EC54-45C7-4285-9180-4FFF1FB3215A Q37775428-E2017A2D-CC35-41A6-A407-FEE376452760 Q38384078-FF8E22FB-F053-4287-AB8B-387CF61A85E5 Q38760574-DD1CAE70-598D-4467-87E1-8EE72D301007 Q38845763-CA13F0A4-EC98-43AA-B7A1-D8DA07A9DD68 Q38993775-C808BC39-53DA-4015-9CB6-9D701819F6C2 Q40278065-90E62E4E-2F4F-4EDA-ABB0-883A5443FFFC Q41890173-A870553F-4A85-4DDE-B10C-6CC960B021A1 Q43070082-88E6B642-126E-4495-B9C4-F8A17CB14E5A

P2860

Short-course postexposure antibiotic prophylaxis combined with vaccination protects against experimental inhalational anthrax

http://www.wikidata.org/entity/Q24546050

description

2006 nî lūn-bûn

@nan

2006 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Short-course postexposure anti ...... erimental inhalational anthrax

@ast

Short-course postexposure anti ...... erimental inhalational anthrax

@en

Short-course postexposure anti ...... erimental inhalational anthrax

@nl

type

label

Short-course postexposure anti ...... erimental inhalational anthrax

@ast

Short-course postexposure anti ...... erimental inhalational anthrax

@en

Short-course postexposure anti ...... erimental inhalational anthrax

@nl

prefLabel

Short-course postexposure anti ...... erimental inhalational anthrax

@ast

Short-course postexposure anti ...... erimental inhalational anthrax

@en

Short-course postexposure anti ...... erimental inhalational anthrax

@nl

P1433

Q24546050-64F3C26F-EBAA-4E90-BC1A-603FCE0E7A5D

P1476

Q24546050-47A32EE5-6C29-4D6D-A13E-79727286A753

P2093

Q24546050-06740C1B-80B7-45D6-B3E4-4EB2EF6EB437

Q24546050-08E7980D-8BEA-4AEB-B42A-5924D3838CD4

Q24546050-1D938886-5A07-4226-8683-10D08BD101E5

Q24546050-3DF9756E-E80A-4B31-919D-355D04BE0C22

Q24546050-4FC2A11D-9065-4CDC-B912-046AAABE8080

Q24546050-7AA5F292-F373-4A28-B635-0139611D16E4

Q24546050-7F96B7D6-EA56-4803-82F4-27D7F73CDC82

Q24546050-80BAC1AE-57BC-453B-BB62-D6A9A245556C

Q24546050-898A8020-3D01-42F9-8F48-5699210D99C3

Q24546050-94B1B5B7-E764-47D4-B758-742EB6C95EBC

P2860

Q24546050-001F142B-7B0F-4AEC-B080-FE2CADAD5E0A

Q24546050-716717F5-7F6E-40E6-A258-95157040702A

Q24546050-8E2830B9-3FDB-4DA5-BC3C-1FB2F7E36FB5

Q24546050-D3726439-28ED-4E51-AFF8-0B827E230B1F

Q24546050-E42D805F-225D-4C97-9C0D-3F7A6ED6D583

Q24546050-F75C3B97-4E3F-43A6-B05C-568480F3E27D

Q24546050-F93B754D-F8C2-4CF4-A7E3-A047965D5371

Q24546050-FDA68F78-53EF-431B-A77B-D546E6E435B5

P304

Q24546050-FCAB6938-D982-40A8-97F6-4F3FB9F0823E

P31

Q24546050-9461D0FB-1F80-421C-8C54-8181F9AEF313

P356

Q24546050-58905218-EBC7-45DE-85FC-7333A509E752

P407

Q24546050-8AD24185-546F-48C9-9CE3-2C6AF304C130

P433

Q24546050-97D84486-7434-4F31-9309-9ACD877983D0

P478

Q24546050-998CA6BB-DA23-4863-9D31-2B6968D9CAAF

P577

Q24546050-1CE566D6-F826-4663-869F-FE39FFE9CAA0

P5875

Q24546050-A68B4EEA-4552-4541-90BF-258E7C5B323F

P698

Q24546050-2981513D-D6BD-49C5-8B9D-6FF0A1A7EA6E

P932

Q24546050-C62FD3EE-9C11-4832-A555-71B28291FD19

P356

PNAS.0602748103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Short-course postexposure anti ...... erimental inhalational anthrax

@en

P2093

Arthur M Friedlander

http://www.w3.org/2001/XMLSchema#string

Bret K Purcell

http://www.w3.org/2001/XMLSchema#string

Bruce E Ivins

http://www.w3.org/2001/XMLSchema#string

Christopher S Gamble

http://www.w3.org/2001/XMLSchema#string

Elizabeth K Leffel

http://www.w3.org/2001/XMLSchema#string

Henry S Heine

http://www.w3.org/2001/XMLSchema#string

James V Lawler

http://www.w3.org/2001/XMLSchema#string

Mary E Wright

http://www.w3.org/2001/XMLSchema#string

Nancy A Twenhafel

http://www.w3.org/2001/XMLSchema#string

Nicholas J Vietri

http://www.w3.org/2001/XMLSchema#string

P2860

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence

Anthrax: clinical features, pathogenesis, and potential biological warfare threat.

Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey.

Update: Investigation of bioterrorism-related anthrax, 2001.

Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis.

Penicillin andB. anthracis

P304

7813-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0602748103

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7109018

http://www.w3.org/2001/XMLSchema#string

P698

16672361

http://www.w3.org/2001/XMLSchema#string

P932

1472527

http://www.w3.org/2001/XMLSchema#string